Want to join the conversation?
For 1Q16, $SNX's Technology Solutions segment revenue fell 2.8% to $2.8Bil vs. 1Q15. After adjusting for the translation effect of foreign currencies, this segment's revenue fell by 0.7% vs. 1Q15. Concentrix revenue rose 0.9% vs. 1Q15 and after adjusting for the translation effect of foreign currencies, this segment's revenue grew 4.5% vs. 1Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?